Billionaire “Shark Tank” investor Mark Cuban is reportedly teaming up with President Donald Trump to expand the TrumpRx drug-pricing platform to include generic medications.
Cuban was set to appear at a Monday afternoon White House announcement of the expansion — marking a pivot for one of the country’s most prominent Democrat-aligned business figures as Trump expands direct-to-consumer prescription-drug sales.
News of Cuban’s expected appearance was reported by Bloomberg News.
The move to add generic drugs to TrumpRx — which doesn’t sell medicine, but points consumers to websites that do — is part of a White House push to lower prescription-drug costs ahead of the midterm elections this fall.
Through his Mark Cuban Cost Plus Drug Company, Cuban sells mail-order medications directly to consumers. He’s one of the country’s most outspoken critics of opaque pharmaceutical pricing systems.
